Key Market Indicators
Sales of antihypertensive medications in Germany are set to reach $407 million by 2026. This is up 0.3% on the 2021 figure of $406.5 million. Since 1991, German demand has decreased by an average of 1.2% each year. Italy, Spain and Australia follow Germany in the rankings.
